Growth Metrics

Pediatrix Medical (MD) Cash from Investing Activities (2016 - 2026)

Pediatrix Medical (MD) has disclosed Cash from Investing Activities for 17 consecutive years, with -$10.3 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 430.55% to -$10.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$18.3 million through Dec 2025, up 48.33% year-over-year, with the annual reading at -$18.3 million for FY2025, 48.33% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$10.3 million at Pediatrix Medical, down from $6.6 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $16.4 million in Q2 2021, with the low at -$41.2 million in Q3 2021.
  • Average Cash from Investing Activities over 5 years is -$10.6 million, with a median of -$11.3 million recorded in 2022.
  • Peak annual rise in Cash from Investing Activities hit 270.69% in 2021, while the deepest fall reached 837.28% in 2021.
  • Over 5 years, Cash from Investing Activities stood at -$15.6 million in 2021, then rose by 27.87% to -$11.2 million in 2022, then dropped by 10.52% to -$12.4 million in 2023, then skyrocketed by 84.4% to -$1.9 million in 2024, then crashed by 430.55% to -$10.3 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$10.3 million, $6.6 million, and -$7.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.